In mammals, the primary role of anti-Mü llerian hormone (AMH) during development is the regression of Mü llerian ducts in males. These structures otherwise develop into fallopian tubes, oviducts, and upper vagina, as in females. This highly conserved function is retained in birds and is supported by the high levels of AMH expression in developing testes. In mammals, AMH expression is controlled partly by the transcription factor, SOX9. However, in the chicken, AMH mRNA expression precedes that of SOX9, leading to the view that AMH may lie upstream of SOX9 and play a more central role in avian testicular development. To help define the role of AMH in chicken gonad development, we suppressed AMH expression in chicken embryos using RNA interference. In males, AMH knockdown did not affect the expression of key testis pathway genes, and testis cords developed normally. However, a reduction in the size of the mesonephros and gonads was observed, a phenotype that was evident in both sexes. This growth defect occurred as a result of the reduced proliferative capacity of the cells of these tissues, and male gonads also had a significant reduction in germ cell numbers. These data suggest that although AMH does not directly contribute to testicular or ovarian differentiation, it is required in a sex-independent manner for proper cell proliferation and urogenital system growth.
INTRODUCTION
Anti-Müllerian hormone (AMH) is a glycoprotein belonging to the transforming growth factor-b (TGF-b) superfamily and is secreted by the gonads, where it plays a role in sexual differentiation. Like other TGF-b family members, AMH signals through a heterodimer complex of type I and type II serine/threonine kinase receptors. In early mammalian development, AMH is synthesized and secreted by Sertoli cells of the embryonic testis, where it directs regression of the paired Mü llerian ducts of males [1] [2] [3] . In females, the ducts differentiate into the fallopian tubes, uterus, and upper vagina throughout a period in which AMH is not expressed [4] . However, AMH is present at postnatal stages in the granulosa cells of females, where it is thought to play a role in follicular recruitment [5] . In mammals, AMH is regulated by a combination of transcription factors, including SOX9, SF1, GATA4, and WT1, and is antagonized by the orphan nuclear receptor DAX-1 [6] [7] [8] [9] [10] [11] [12] [13] . Of these proteins, the most important transcription factor for activation of mammalian AMH is most likely SOX9 [6] , which is one of the earliest markers of Sertoli cell differentiation. Mutations in human AMH can lead to persistent Müllerian duct syndrome in males [14, 15] , and the experimental manipulation of AMH in mice influences proper sexual development. Although AMH-deficient male mice can produce functional sperm, most are infertile due the persistence of female reproductive organs [16] , whereas female mice chronically overexpressing AMH do not develop a uterus or oviducts and have ovaries that contain seminiferous-like structures [17] .
AMH expression is preserved amongst vertebrate embryos, being male enriched in species ranging from fishes to reptiles and birds [2] , including chickens [18] [19] [20] . Although in mammals its most apparent link relates to Müllerian duct regression, additional roles for AMH and the importance of its receptor have also been identified. A sex-linked duplicated copy of AMH was analyzed in a teleost fish, the Patagonian pejerrey (Odontesthes hatcheri) [21] . In this fish species, which uses an XX (female)-XY (male) sex determination system, the expression of the Y-linked version of AMH (AMHY) precedes that of the autosomal copy and is restricted to the presumptive Sertoli cells. Suppression of AMHY allows up-regulation of the female pathway factors FOXL2 and the cytochrome P450 family member cyp19a1a, which leads to the development of ovaries. Other studies have examined the hotei mutation of AMHR2 in medaka fish, which results in dysregulation of germ cell proliferation and causes sex reversal in 50% of genetic males [22, 23] . AMH has also been shown to underlie the phenomenon known as the freemartin effect in cattle, whereby a female embryo is masculinized by secreted AMH from its male twin via placental anastomoses [24, 25] . Furthermore, AMH is capable of causing testis cord formation and production of testosterone rather than estrogen in sheep and rat ovaries in organ culture [25, 26] . In chickens, grafting of differentiated testes to the chorionic vasculature of female embryos prior to sexual differentiation results in a freemartinlike effect [27, 28] . In this case, AMH has been implicated as the likely causative hormone, yet this has never been definitively shown. All of these previous studies point to a possible key role for AMH in embryonic gonadal sex differentiation, independent of its role in the Müllerian ducts, at least in nonmammalian vertebrates.
The aim of the current study was to test the requirement of AMH for gonadal sex differentiation in the chicken embryo, given its early and strongly sexually dimorphic expression profile. In chicken, the Z-linked gene DMRT1 is required for testis development and is likely to be the master avian sex determinant, based on a dosage mechanism [29] . A short time after DMRT1 is expressed, AMH mRNA is detectable, followed by SOX9 mRNA [18] [19] [20] , an observation that is also seen in alligators [30] . Critically, SOX9 is expressed in the embryonic testis cords, where, by analogy with other vertebrates, it is thought to trigger differentiation of the Sertoli cell lineage. Unlike in mouse, AMH mRNA is present in the embryonic chicken gonads of both sexes, as both the paired male and the right female Müllerian ducts regress [31] . The action of local estrogens is thought to protect the left duct from regression in females [4, 32, 33] , although the exact mechanism of this has not been established. Considering the early timing of AMH expression, as well as the observation that in female gonads AMH expression is detected in the absence of SOX9, other factors, such as SF1, must initiate AMH mRNA expression in birds (although SOX9 could contribute to its male upregulation). This raises the possibility that AMH could function at an early step in the sex determination cascade in chickens.
To test this hypothesis, we used RNA interference (RNAi) to suppress the expression of AMH in male and female embryonic gonads.
MATERIALS AND METHODS

Ethics
All experimental work adhered to the Australian code of practice for the care and use of animals for scientific purposes (7th ed., 2004) and according to in-house animal handling guidelines (Murdoch Children's Research Institute and CSIRO Australian Animal Health Laboratory).
Embryo Incubation and Tissue Collection
All experiments were carried out on a single line of specific pathogen-free embryos (SPAFAS) from the White Leghorn strain of chick (Lohman-LSL) and incubated at 37.88C with rocking in a humidified incubator.
AMH Overexpression and RNAi
To clone the AMH open reading frame, RNA was extracted from a Hamburger-Hamilton stage 36 (HH 36) ZW female chicken embryo using TRI-ZOL Reagent (Invitrogen). RNA was then DNAse treated using the DNA-free kit (Ambion), and cDNA was synthesized using the First Strand cDNA Synthesis Kit (Roche). The AMH open reading frame was PCR amplified from cDNA using forward primer 5 0 -AAGGCGGCTCTCGGGGTG-3 0 and reverse primer 5 0 -ATTACGAATTCGCACAGCCCCACAGAGTAAAA-3 0 with an included EcoRI site. The resultant 2046-bp fragment was subcloned into the NcoI and EcoRI sites of pSLAX-13. The AMH sequence was then excised using ClaI and cloned into pCMV-Script (Agilent Technologies) using the ClaI site downstream of the CMV promoter, and its orientation and sequence were confirmed by DNA sequencing.
For AMH suppression, we used the avian retroviral vector RCANBP [34] [35] [36] to express short hairpin RNAs (shRNA) for RNAi. A PCR-based approach to amplify the chicken U6-4 promoter along with the shRNA template was used. A PCR with a plasmid encoding the chicken U6-4 promoter (pGEMchU6-4) [37] as the DNA template, a universal forward primer with a ClaI site and the first 20 nt of the 5 0 end of the U6-4 promoter sequence (5 0 -GGTTATCGATGCATGCGTACCTCCTTCTCG-3 0 ), and a reverse primer encoding each different shRNA were used. The reverse primers consisted of all shRNA template components, including a U6-4 primer site, the shRNA stem and loop sequences, and a pol III termination sequence [38] . An example (5 0 -3 0 ) is shown for the nonsilencing control shRNA (shNS), which consisted of the last 18 nt of the U6-4 promoter (AAACCCCAGTGTCTCTCG), plus the shRNA sense (TATGTCAACTATGTTAGCT), miR-30 loop (TA CATCTGTGGCTTCACTA), shRNA antisense (AGCTAACATAGTTGACA TA), and termination sequence with a ClaI site (AACCATCGATAAAAAA). For the AMH-specific shRNAs, the same format was used, except the shRNA sense sequences (and corresponding antisense sequences) were exchanged with sequences as follows: AMH-sh151 (5 0 -TGAGATGGGACTTGGAGCAAAG-3 0 ), AMH-sh396 (5 0 -CTGAAAGTGCCTTCATCAAAGT-3 0 ), and AMHsh1873 (5 0 -ACGTTACTCGGACCAACTCATC-3 0 ). Amplified PCR products were then digested with ClaI and ligated into RCANBP/A directly on ClaI, and their forward orientation and sequence were confirmed by DNA sequencing. Proviral DNA was then transfected into chicken fibroblastic DF1 cells using Lipofectamine 2000 (Invitrogen) and propagated for approximately 2 wk. Immunostaining for AMH and the viral protein p27 at this stage confirmed infection and ectopic AMH expression in vitro. Recombinant virus was harvested from culture medium, concentrated by ultracentrifugation, and titered as previously described [39] . High-titer virus (approximately 10 8 infectious units/ml) was microinjected into Day 0 blastoderms, and eggs were sealed with parafilm and incubated at 37.58C before being harvested at Embryonic Day 7.5 (E7.5 [HH 32]) [40] . Control embryos were either untreated or injected with RCANBP-shNS virus, which expressed a nonsilencing control shRNA. These experiments were repeated at least three times and involved at least 50 embryos for each experiment.
PCR Sexing
Infected and control embryos were dissected at indicated time points. For genetic sexing of embryos, a small piece of limb tissue was digested in PCRcompatible Proteinase K buffer, and the genomic DNA was used for rapid PCR sexing [41] . By this method, only females show a W-linked (female-specific) XhoI band. Amplification of 18S rRNA in both sexes served as an internal control.
Immunofluorescence and Cell Counting
Control and RCANBP-infected tissues were fixed for 15 min in 4% paraformaldehyde (PFA)/PBS at room temperature prior to processing for tissue section immunofluorescence, as described previously [42] . At least three embryos per time point and/or treatment were examined. Briefly, 10-lm sections were cut on a cryostat, permeablized in PBS 1% Triton X-100, and blocked in PBS 2% BSA for 1 h. Primary antibodies were either raised in-house (rabbit anti-chicken aromatase [ [43] . PH3-and Vasa-positive cells in representative transverse sections were counted as a percentage of total DAPI-positive cells. All samples were tested in at least triplicate (an example is shown in Supplemental Fig. S1 ; Supplemental Data are available online at www. biolreprod.org).
Quantitative Real-Time PCR
Quantitative real-time (qRT-PCR) for cAMH mRNA expression was performed in using SYBRGreen PCR Master Mix (Applied Biosystems) following the manufacturer's instructions and using Roche real-time PCR machine. Reactions were performed in triplicate, with two gonad pairs per replicate. The primers used were chicken b-actin: 5 0 GCTACAGC TTCACCACCACA-3 0 and 5 0 -TCTCCTGCTCGAAATCCAGT-3 0 and chicken AMH: 5 0 -GAAGCATTTTGGGGACTGG-3 0 and 5 0 GGGTGG TAGCAGAAGCTGAG-3 0 Primer efficiencies of 90%-110% were confirmed prior to their use in the PCR. Data were analyzed using the DDCt method and normalized to b-actin mRNA expression, and statistical significance was assessed using unpaired t-test.
RNA Sequencing
RNA sequencing on E4.5 and E6.0 chicken embryos was carried out using the Illumina HiSeq2000 at Australian Genome Research Facility in Melbourne, Australia. The methods used for RNA extraction, sequence data analysis, and assembly of E4.5 data were described previously [44] . The E6.0 data were LAMBETH ET AL. 
Whole-Mount In Situ Hybridization
The whole-mount in situ hybridization method has been described in detail previously [20, 45] . At least three embryos were used for each analyzed condition. The urogenital systems of E7.5 embryos were dissected under RNase-free conditions and fixed overnight at 48C in 4% PFA/PBS. Following fixation, tissues were dehydrated through a methanol series, followed by rehydration and digestion with proteinase-K in PBS with 0.1% Triton-X 100 for 60 min. Samples were then refixed in 4% PFA/PBS and incubated overnight at 658C in prehybridization buffer. For riboprobe synthesis, a region of the AMH and HSD3b sequence were PCR amplified from cDNA and cloned into pGEM-T Easy (Promega). Riboprobe templates for each were generated by PCR using M13 forward and reverse sequencing primer sites. Antisense probes were then synthesized using SP6 or T7 RNA polymerase and labeled with digoxygenin (DIG). Probes were added to tissues overnight in hybridization solution and washed at 1% and 0.1% SSC stringencies, and alkalinephosphatase conjugated DIG antibody was added after preblocking in TBTX buffer (pH 7.0) containing BSA and sheep serum. Tissues were then extensively washed in TBTX 0.1% BSA, and the chromogen was added (NBT/BCIP in Tris-based buffer, pH 9.0). Color reactions were carried out at room temperature over 2-4 h prior to imaging. For sectioning, tissues were placed back into chromogen solution and incubated at room temperature over 2 days and then cryoprotected by placing into 30% sucrose/PBS overnight at 48C. Following embedding in OCT compound and snap freezing on dry ice, tissue samples were cut on a cryostat at 10-18 mm and mounted onto slides with Aquamount.
RESULTS
Time Course Analysis of AMH and SOX9 Protein Expression in Early Stage Male Embryonic Gonads
It has previously been reported that AMH mRNA is expressed in male gonads prior to SOX9 [19, 20] . To provide a more detailed analysis of the timing of AMH and SOX9 protein expression throughout the time of gonad differentiation, a time course was carried out on male gonads using immunofluorescence (Fig. 1) . It was found that at HH 27 (E5.0-E5.5), neither of these proteins could be detected. Both proteins were present by HH 28 (E5.5-E6); however, SOX9 was more widespread than AMH. This trend continued at the next stage development, as at HH 29 (E6-E6.5), SOX9 was still more prevalent than AMH; however, by HH 30 (E6.5-E7), nearly all SOX9-positive cells were also expressing AMH. These data indicate that despite the previous observations that AMH mRNA expression precedes that of SOX9, the first detection of these two proteins occurs at the same developmental stage. However, at this time, more SOX9 was detected, and its expression was more widespread throughout the gonad compared to AMH.
Suppression of AMH by RNAi
To test the effect of AMH suppression in chicken embryonic gonads, effective shRNA molecules were first identified in vitro. For this assay, shRNAs were delivered via the avian retrovirus RCANBP/A and tested for their efficacy in suppressing AMH protein transiently expressed in DF1 cells. Overexpression of AMH in vitro was first established using a pCMV plasmid (pCMV-AMH). This expression plasmid was tested in chicken fibroblastic DF1 cells (Supplemental Fig. S2 ). Recombinant AMH protein was clearly visible by immunofluorescence, although the expression level was lower than that of the reporter gene Red Fluorescent Protein (dsRED) or cHEMGN, which were included as positive controls. This is likely due to the nature of AMH protein, as it is a readily secreted molecule. Next, shRNA sequences downstream of the chicken U6-4 promoter were cloned into RCANBP and used to infect DF1 cells for 7 days prior to transfection of pCMV-AMH. Screening of three shRNA sequences showed that compared to the negative control shRNA, AMH-sh151 provided the most effective AMH knockdown, as determined by immunostaining using the anti-AMH antibody (Supplemental Fig. S3 ). 
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For AMH knockdown in ovo, the RCANBP-AMH-sh151 and RCANBP-shNS viruses were microinjected into blastoderm stage chicken embryos, and at E7.5 the urogenital systems were removed. A total of 18 RCANBP-AMH-sh151-infected male embryos were analyzed, all of which showed a clear urogenital phenotype, characterized by a reduction in the size of the mesonephros and gonads. Importantly, this phenotype was limited to the urogenital system, as this reduction in size was observed in these tissues only. Widespread infection of both viruses in male gonads was confirmed by immunostaining for the viral epitope (anti-p27), which was not present in the uninfected control ( Fig. 2A) . AMH-sh151 expression resulted in a strong reduction in the amount of AMH protein detected compared to the uninfected male gonad and RCANBP-shNS-infected control gonads ( Fig.  2A) . A phenotypic effect of this knockdown was evident by whole-mount bright-field microscopy, as the mesonephros and gonads were reduced in size compared to both controls (Fig.  2B) . The relative levels of AMH mRNA in gonad tissues were then measured by qRT-PCR. It was found that there was a significant reduction in both males and females (Fig. 2C) .
Effect of AMH Knockdown on Testis Development
The effect of AMH suppression on male gonad development was then analyzed by immunofluorescence and whole-mount in situ hybridization. The expression of testis pathway genes DMRT1 and SOX9 was assessed first (Fig. 3A) . Immunostaining of the control males indicated normal expression levels and distribution of these proteins, as expression for each was confined to seminiferous cords (Fig. 3A) . In the RCANBP-AMH-sh151-infected male gonads, the suppression of AMH did not affect the expression of either DMRT1 or SOX9, as the expression patterns of these proteins was similar to those of the male controls (Fig. 3A) . To test if AMH knockdown in male gonads affected the AMH receptor, immunostaining for this protein together with the extracellular matrix glycoprotein fibronectin was carried out (Fig. 3A) . The recently characterized receptor for chicken AMH (AMHR2) is strongly expressed in males after the onset of gonadal sex differentiation and colocalizes with AMH within Sertoli cells of the testis cords [46] . In males, fibronectin delineates basement membrane and hence outlines testis cords. The male gonads expressing AMH-sh151 had a similar intensity and arrangement of AMHR2 staining to the control male, indicating that AMH suppression did not affect AMHR2 expression. In addition to male-specific gonad developmental genes, the potential for steroidogenic activity in male gonads with reduced AMH expression was analyzed by whole-mount in situ hybridization for HSD3b. Strong HSD3b expression was evident in the gonads of both controls, and although the gonads were considerably smaller, HSD3b was also expressed in both the left and the right gonads of the male infected with RCANBP-AMH-sh151, suggesting that the steroidogenic pathway was unaffected (Fig. 3B) .
The presence and location of male germ cells was then analyzed by immunostaining for the Vasa protein homologue (Fig. 3C) . Since DMRT1 is expressed in both Sertoli and germ cells, costaining of these proteins was used to identify these cell types. In the control shNS male, the majority of DMRT1 protein detected was from the nuclei of Sertoli cells located within testis cords, whereas the double-positive DMRT1 and Vasa germ cells were in much lower numbers. In the AMHsh151-expressing male, the levels and location of DMRT1 was similar to the control; however, there were fewer germ cells overall. To quantitate this reduction, automated image analysis was used to count Vasa-positive cells compared to total cells marked by DAPI (Fig. 3C) . A significant reduction was found compared to the shNS control, from greater than 7% to approximately 2%. Therefore, the suppression of AMH negatively affected the growth of the male mesonephros and gonads and the number of germ cells. However, the signaling of testis pathway genes and the molecular structure of the gonads, as well as the steroid biosynthetic pathway, were unaffected.
Effect of AMH Knockdown on Ovarian Development
Although AMH expression is upregulated in a male-specific manner at the time of gonadal differentiation, the expression of AMH mRNA in female chicken gonads at this time has also been reported [20] . Furthermore, it was observed that like in the males, AMH mRNA was also suppressed in female gonads following RCANBP-AMH-sh151 infection (Fig. 2C) . For a more detailed analysis of this observation, we analyzed AMH expression in female gonads by whole-mount in situ hybridization and RNA sequencing (RNA Seq) immediately before and after gonads undergo sexual differentiation (Fig. 4) . Staining for AMH mRNA by whole-mount in situ hybridization showed that in male gonads, low levels of AMH were present at E4.5 and that by E6.5 the signal for AMH was very strong (Fig.  4A ). The expression of AMH mRNA was also evident from E4.5 in females and became stronger at E6.5 and E9.5 (Fig.  4A) . The location of this staining was shown by sectioning of these gonad tissues, which also confirmed the AMH signal in female gonads from E4.5 (Fig. 4A) . The sequencing of chicken gonad RNAs was carried out as part of a separate study, some of which has been published previously [44] . Further analysis of these data, as well as additional data from E6.0 embryonic gonads (Ayers et al., unpublished data), showed that by comparing the ratio of read counts for male to females, AMH was the most dimorphic of all RNAs present at E6.0, as the male:female fold change in fragments per kilobase of exon per million fragments mapped was the highest overall (Fig. 4B) . These data underscore the high level of AMH expression in testis but also that AMH mRNA is also clearly expressed in females.
To assess the effect of AMH suppression in female gonads, blastoderm stage embryos were infected with RCANBP-AMHsh151 and analyzed at E7.5. A total of 27 RCANBP-AMHsh151 infected female embryos were analyzed, which, with the exception of two individuals, showed a clear phenotype. As with the males, knockdown of AMH in female embryos resulted in a reduction in the size of both the mesonephros and the gonads, while the rest of the embryo was normal in size (Fig. 4C) . Widespread infection of both viruses was confirmed by p27 staining, which was not present in the uninfected control. Immunostaining for AMH was then assessed to visualize AMH suppression. However, unlike in the male gonads, the anti-AMH antibody was unable to detect this protein, most likely due to insufficient sensitivity (Fig. 4C) . Suppression of AMH mRNA by RNAi was therefore visualized by whole-mount in situ hybridization. A clear signal was detected for the controls, whereas little or no signal was evident in the RCANBP-AMH-sh151-infected female gonads, reiterating the effective AMH suppression measured by qRT-PCR (Fig. 2C) . The phenotypic effect of this suppression was also evident in these images, as the mesonephros was reduced in size, as were the right and left gonads.
To analyze the effect of AMH knockdown on the molecular development of female gonads, tissues were immunostained for the female-specific protein aromatase together with fibronectin LAMBETH ET AL.
FIG. 2. Suppression of AMH by
RNAi in male gonads. RCANBP viruses expressing AMH-sh151 or a nonsilencing control (shNS) were used to infect blastoderm stage embryos, and at E7.5 urogenital systems were analyzed and compared to uninfected controls. A) Immunostaining for the viral p27 (green) shows widespread RCANBP infection in the left gonads for shRNA-expressing gonads. Immunostaining for AMH protein (green) shows that its expression was suppressed in the AMH-sh151 left gonad compared to the controls (original magnification 310). B) Whole-mount bright-field images of urogenital systems either uninfected or infected with shRNA viruses, with the mesonephric kidneys (Ms) and the right gonad (Rg) and left gonad (Lg) delineated by the black dashed lines (original magnification 34). The mesonephros and both left and right gonads of the AMH-sh151-expressing embryos were reduced in size. C) Knockdown of AMH mRNA expression in gonads measured by qRT-PCR (mean 6 SEM, n ¼ 3, *P , 0.05). Messenger RNA expression is significantly reduced in both sexes. (Fig. 5A) . Aromatase (CYP19A1) is a cytochrome P450 enzyme, shows female-specific expression from the time of gonadal sex differentiation [18-20, 45, 47, 48] , and, along with several other steroidogenic enzymes, catalyzes estrogen synthesis. In females, fibronectin outlines medullary cords and delineates the fibronectin negative cords. There was strong aromatase expression in the medulla of the control females and in the RCANBP-AMH-sh151-infected female (Fig. 5A) . In addition, the fibronectin staining showed that all gonads had a thickened outer cortex, a trait that is present in female left gonads at this stage but not in males. The presence and location of germ cells was then analyzed by immunostaining for Vasa protein and DMRT1. In female gonads, these proteins are coexpressed exclusively in the germ cells. In both the control 
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female and the AMH knockdown left gonads, Vasa and DMRT1 coexpressed in the same cells and showed a typical germ cell arrangement with cells concentrated in the thickened outer cortex (Fig. 5A) . The distribution and numbers of germ cells in the AMH-sh151-treated gonad appeared to be similar to that of the control. The potential for steroidogenic activity in female gonads with suppressed AMH was then assessed by whole-mount in situ hybridization for HSD3b (Fig. 5A) . There was strong HSD3b expression in the gonads of the female controls, and despite the reduced size of the female gonads expressing AMH-sh151, the levels of HSD3b appeared to be unaffected.
Since the right gonads of AMH knockdown females also had a marked reduction in size, these were also analyzed by immunofluorescence (Fig. 5B) . Compared to the control right gonads, a similar level and expression pattern of aromatase was present, and counterstaining with fibronectin also showed that all shared a similar structural arrangement. This was also true of DMRT1 and Vasa, as both of these proteins were expressed in the same cells for all conditions tested and appeared to resemble similar levels and distribution for each. Although there was no obvious difference in the expression of these proteins, these images highlighted that the appearance of the AMH-sh151-treated right gonad was altered compared to the controls, being flattened and smaller. To quantitate germ cell numbers, automated image analysis was used to count Vasapositive cells compared to total cells marked by DAPI in left and right gonads of females with suppressed AMH (Fig. 5B) .
FIG. 4. Expression of AMH and suppression by RNAi in female gonads.
A) Whole-mount in situ hybridization for AMH mRNA in male and female gonads at E4.5, E6.5, and E9.5. Imaging of both whole-mount urogenital systems and sectioned tissues shows strong male expression and clear female expression in both gonads from E4.5. B) Total read counts for AMH mRNA in gonads measured by RNA Seq. show detection of AMH from E4.5 in female gonads, which increases at E6.0. C) Blastoderm stage embryos were infected with RCANBP viruses expressing shNS or AMH-sh151, and at E7.5 female urogenital systems were analyzed. Images for immunofluorescence are of left gonads, and bright-field images show the right gonad (Rg) and left gonad (Lg) delineated by black dashed lines. Whole-mount bright-field images of urogenital systems either uninfected or infected with shRNA viruses, showing a reduction in size of the AMH-sh151-treated embryo (original magnification 34). Immunostaining for the viral p27 (green) shows widespread RCANBP infection in the left gonads for shRNA-expressing gonads. Immunostaining for AMH protein (green) resulted in poor AMH protein detection (original magnification 310). Whole-mount in situ hybridization for AMH shows a clear reduction in both the size and the amount of AMH mRNA in the AMHsh151 gonads compared to the controls (original magnification 34).
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FIG. 5. Effect of AMH suppression on the development of the ovarian pathway. RCANBP viruses expressing AMH-sh151 or a nonsilencing control (shNS) were used to infect blastoderm stage embryos, and at E7.5 female urogenital systems were analyzed and compared to uninfected controls. A) Immunostaining for aromatase (green), fibronectin (red), and DAPI (blue) in left gonads showed similar patterns and intensity of expression for each condition. Immunofluorescence on left gonads for DMRT1 (green) and Vasa (red) as merged images showed that the distribution and numbers of germ cells were similar for each (original magnification 310). Whole-mount in situ hybridization for HSD3b, with the right gonad (Rg) and left gonad (Lg) LAMBETH ET AL.
Despite a trend toward a reduction in Vasa-positive germ cells, this difference was not significant compared to the shNS control. Overall, the suppression of AMH in females produced a similar phenotype to that seen in males, negatively affecting the growth but not the sex-specific molecular development of embryonic gonads; however, the effect on germ cell numbers was less prominent.
AMH Suppression Negatively Affects Cell Proliferation
To further analyze the effect of AMH knockdown on urogenital system development, cell proliferation was monitored by immunostaining for phospho histone 3 (PH3). PH3 is a marker of M phase and is therefore indicative of the replicative status of a population of cells. Blastoderm stage embryos were infected with RCANBP-AMH-sh151, and urogenital systems were analyzed at E7.5 for PH3 expression (Fig. 6A) . It was found that compared to the male and female controls, there was a strong reduction in the number of PH3-positive cells throughout the mesonephros and gonads of sh151-treated embryos of both sexes. To quantitate these changes, automated image software was used to count the number of PH3-positive cells compared to all cells (DAPI) of the gonads and mesonephroi. It was found that there was a significant reduction in the number of PH3 cells in both the gonads and the mesonephroi with suppressed AMH compared to the controls (Fig. 6B) . Interestingly, this reduction was greatest in both the gonads and the mesonephroi of females, with more than a 5-fold reduction in the gonads. In addition, fibronectin staining also showed that the Müllerian ducts of the shNS control male were considerably smaller than the control female. In contrast, the Müllerian ducts of the sh151-treated male were larger and of comparable size to all females, suggesting that the suppression of AMH interfered with normal duct regression (Fig. 6A) .
DISCUSSION
To better understand the role of AMH in avian sex differentiation, we used RNAi to suppress the expression of this protein in chicken embryos. Several lines of evidence suggest that AMH might play a key role in the male program of gonad development. The masculinization of genetic females transplanted with differentiated testes implied that secreted factors such as AMH might have been responsible for this effect [27, 28] . Furthermore, the location and early timing of its expression in male gonads is also consistent with a more prominent role for this protein in testis pathway signaling. The current study is the first to describe the direct manipulation of AMH expression in chicken embryos and as such provides novel insights into the role of this hormone in avian sex differentiation.
Given the lack of clarity surrounding the exact timing of SOX9 and AMH protein expression in male embryonic gonads during sex differentiation, we decided to examine these two proteins at half-day intervals across this period (equivalent to successive developmental stages). Despite the early expression of AMH mRNA previously reported [19, 20] , we found that SOX9 protein is present earlier and is more widespread than AMH protein throughout the period in which male and female gonads begin differentiating. It must be noted that this method relies on the affinity of these antibodies for their target epitopes and may not perfectly represent the detailed expression abundance and patterns of these proteins. Nevertheless, these data show that the timing and expression of AMH and SOX9 proteins are very similar in chicken. Hence, while SOX9 may not initiate AMH mRNA transcription, it is possible that it regulates AMH mRNA translation into active protein. However, there is not yet any direct evidence to support this.
Using the avian retroviral RCANBP, AMH expression was suppressed by the transcription of an AMH-specific shRNA. The effect of this knockdown was determined at E7.5, just after the onset of gonadal sex differentiation at E6.5. By this stage, all key testis and ovarian developmental proteins can be detected, and the Müllerian ducts have just started to regress. In males, testis cords can be identified, and in females, the right ovary has begun regression, whereas the left ovary is larger and has a thickened outer cortex. We have previously reported that manipulation of key genes such as DMRT1 [49] and CYP19A1 [50] at this stage of gonad development blocks proper male and female gonadal development, respectively. In the current study, positive confirmation of the suppression of AMH was evident by fibronectin staining on cross sections of whole urogenital systems, which suggested that duct regression was indeed blocked as a result of AMH knockdown in males (Fig. 6) .
To analyze the effect of AMH knockdown on embryonic gonadal development, tissues were assayed for key testis genes, DMRT1 and SOX9, as well as aromatase in females. The enzymatic action of HSD3b is essential for the production of all active steroid hormones [51] and therefore a benchmark indicator of steroidogenic potential. In the current study, despite strong suppression of AMH in the male gonads at E7.5, no direct effect on the expression of key testis pathway genes was observed. The expression of DMRT1 and SOX9 showed patterns of expression and levels that were consistent with the controls, which also highlighted the correct development of testicular cords and therefore presumably Sertoli cells. In addition to these genes, the expression AMHR2 and HSD3b also appeared to be undisturbed, further suggesting that the testis pathway and steroid synthesis pathways remained intact. Of particular note, however, was the reduction in the size of the mesonephros and gonads. This reduction in size was also evident in female gonads, which express much lower levels of AMH. Indeed, a significant reduction in the number of cells undergoing mitotic cell division was observed by immunostaining for PH3 expression in both sexes, suggesting that the reduced size of these urogenital systems occurred as a result of impaired proliferative potential. Importantly, the receptor for AMH, AMHR2, is expressed in the gonads and Müllerian ducts of both sexes [46] , suggesting that AMH might be important in urogenital development in both sexes.
Consistent with the observations in the treated males, AMH suppression in the female gonads did not specifically affect ovarian marker gene expression, and the left gonad developed a thickened outer cortex with robust aromatase and HSD3b expression. It was therefore interesting that the effect of suppressing this male upregulated gene produced a similar phenotype in both sexes. One difference between the sexes, however, was the reduction of Vasa-positive germ cells. In males, a significant reduction of greater than 3-fold was observed compared to the control, whereas in females, only a small and nonsignificant reduction was evident. It is unclear if this reduction occurred due to decreased proliferation of PGCs or by impairment of the migration of these cells to the gonads.
Considered together, these data suggest that in addition to its role in Müllerian duct regression, AMH influences sexindependent development of the embryonic urogenital system, including the gonads. Critically, these data also indicate that AMH does not contribute specifically in testis-specific signaling in the chicken embryo despite implications from the literature. Considering that a similar phenotype was found FIG. 6 . AMH suppression negatively affects urogenital cell proliferation. RCANBP viruses expressing AMH-sh151 or a nonsilencing control (shNS) were used to infect blastoderm stage embryos, and at E7.5 urogenital systems were analyzed by immunostaining for PH3 (green) and fibronectin (red) (original magnification 34). A) The right (Rg) and left (Lg) gonads and the right (R-MD) and left (L-MD) Mü llerian ducts are delineated by white dashed lines. The Mü llerian ducts of the control male are smaller than the AMH knockdown urogenital system (white arrows), suggesting that AMH suppression blocked Mü llerian duct regression. B) Quantitative analysis of cell proliferation. PH3-positive cells were counted using Fiji image analysis software and expressed as a percentage of total DAPI-positive cells. Cell proliferation was lower in the knockdown gonads and mesonephroi (unpaired t-test; *P , 0.05; **P , 0.01; n ¼ 3-4, 6 SEM). A reduction in the number PH3-positive cells was observed in the urogenital systems of both males and females with suppressed AMH compared to shNS controls, indicating that fewer cells were undergoing mitotic cell division.
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in both sexes, we conclude that like other TGF-b family members [52] , AMH is required for correct urogenital development, including proper growth, proliferation, and germ cell migration. The influence of AMH on such processes has been demonstrated in a previous study in which the treatment of embryonic female mice gonads in culture with recombinant AMH induced mesonephric migration and led to an altered morphology and vasculature [53] . Furthermore, since impaired AMH signaling in medaka resulted in dysregulation of germ cell proliferation [22, 23] , this might also be the case in chickens. Furthermore, it is likely that a reduction in testis size and germ cell numbers in these males would lead to subfertility in adults.
Although the method of RNAi used in the current study offered effective suppression of AMH expression in ovo, it is possible that residual AMH protein as a result of incomplete suppression may have been sufficient for testis-specific signaling. However, since AMH knockdown resulted in a clear urogenital phenotype, which included blocking Müllerian duct regression, it would be expected that this reduction would have at least some effect on testis pathway development if AMH were required for proper signaling. Indeed, suppression of DMRT1 by RNAi produces a spectrum of effects on testis development, from moderate to complete gonad sex reversal [29] . The production of AMH knockout chickens would definitively answer this question; however, rapid methods for effective transgenesis in this species remain technically challenging. Nevertheless, these data suggest that the levels of AMH suppression were sufficient to disrupt normal AMH signaling in the gonads of both sexes and thereby provides new evidence for its role in embryonic development.
In summary, we employed a viral-based method for the suppression of AMH expression in chicken embryos. AMH knockdown did not directly affect the expression of key testis development genes, as both DMRT1 and SOX9 remained unperturbed. However, its suppression did affect urogenital system morphology, as both male and female embryos showed a considerable reduction in the size of these structures, including the gonads. Consistent with the lack of direct effect on testis signaling, the ovarian pathway of females with suppressed AMH was also undisturbed despite the reduction in gonad size. These findings are in agreement with those reported in mouse, where loss of AMH in males and overexpression in females does not have a decisive effect on gonadal sex differentiation [16, 17] . It is therefore likely that in chickens, AMH is not required directly for testis signaling but plays an important sex-independent role in urogenital system growth and development.
